The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(2-Chloro-6-methylphenyl)-2-((4-chlorophenyl)amino)thiazolo[4,5-d]pyrimidin-7(6H)-one ID: ALA4474766
PubChem CID: 124121429
Max Phase: Preclinical
Molecular Formula: C18H12Cl2N4OS
Molecular Weight: 403.29
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cccc(Cl)c1-n1cnc2nc(Nc3ccc(Cl)cc3)sc2c1=O
Standard InChI: InChI=1S/C18H12Cl2N4OS/c1-10-3-2-4-13(20)14(10)24-9-21-16-15(17(24)25)26-18(23-16)22-12-7-5-11(19)6-8-12/h2-9H,1H3,(H,22,23)
Standard InChI Key: LYGNZPBMFQPVFI-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
33.0134 -15.1125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.7231 -14.7030 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7203 -13.8804 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.0116 -13.4751 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3054 -14.7035 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3021 -13.8870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5245 -13.6378 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
31.0472 -14.3003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5299 -14.9589 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.4234 -13.4704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1329 -13.8780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8386 -13.4675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8360 -12.6494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1218 -12.2436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4190 -12.6566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2300 -14.3037 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.0090 -12.6579 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.7086 -12.2526 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1352 -14.6952 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
29.8185 -13.5976 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2253 -12.8905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.8145 -12.1850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9964 -12.1879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5909 -12.9022 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0040 -13.6049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5840 -11.4824 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 2 0
2 3 1 0
3 4 1 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
9 5 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
3 10 1 0
8 16 1 0
4 17 2 0
15 18 1 0
11 19 1 0
16 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
23 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 403.29Molecular Weight (Monoisotopic): 402.0109AlogP: 5.20#Rotatable Bonds: 3Polar Surface Area: 59.81Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.64CX Basic pKa: ┄CX LogP: 5.84CX LogD: 5.84Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.51Np Likeness Score: -1.80
References 1. Li Y, Sun L, Yang T, Jiao W, Tang J, Huang X, Huang Z, Meng Y, Luo L, Wang X, Bian X, Zhang F, Wang K, Sun Q.. (2018) Design and Synthesis of Novel Positive Allosteric Modulators of α7 Nicotinic Acetylcholine Receptors with the Ability To Rescue Auditory Gating Deficit in Mice., 62 (1): [PMID:29587480 ] [10.1021/acs.jmedchem.7b01492 ]